Trailing-twelve-month (TTM) revenue is $10.69 Million with a year-over-year growth of (80.95%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $8,242,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $1,808,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $565,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $75,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $10,690,000 |
Current P/S: $2,589,675,392 market capitalization ÷ $10,690,000 TTM revenue = 242.25x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $75000.00.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T23:21:12.602Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Other | $411,000 | $134,000 |
$10.69M
$10.69 Million
(80.95%)
vs. $56.12M a year ago (TTM)
+120.81%
5 Year compound annual growth rate
1 Year
(80.95%)
3 Year
(15.80%)
5 Year
+120.81%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $31.48M | ($5.57M) | (15.02%) |
| 2024 | $37.05M | +$14.23M | +62.41% |
| 2023 | $22.81M | +$11.01M | +93.24% |
| 2022 | $11.80M | +$8.94M | +312.44% |
| 2021 | $2.86M | +$2.26M | +377.00% |
| 2020 |
TTM Growth
(80.95%)
3-Year CAGR
(15.80%)
5-Year CAGR
+120.81%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T23:21:12.602Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
| $600,000 |
| +$227,000 |
| +60.86% |
